Affiliation:
1. Department of Microbiology and Parasitology, Faculty of Pharmacy, Ramon y Cajal Health Research Institute (IRYCIS), Complutense University of Madrid (UCM), Madrid, Spain
Abstract
Invasive Candidiasis (IC) poses a major public health problem worldwide. Despite the introduction
of new antifungal agents and changes in clinical practices, its morbidity and mortality rates and
healthcare costs remain persistently high. This is mainly because of the serious underlying conditions of
infected patients (critically ill or severely immunocompromised patients) and the difficulties encountered
in early diagnosing this opportunistic mycosis and initiating prompt and appropriate antifungal
therapy. In the light of this great clinical challenge, the past decades have witnessed the development of
diverse early detection and therapeutic intervention strategies aimed at minimizing the clinical impact
and economic burden of this healthcare-associated infection caused by Candida species. Here, we review
the currently available methods for IC diagnosis. These encompass (i) gold standard methods (fungal
culture and tissue histopathology), (ii) pathogen-derived biomarker detection tests (PCR, protein antigens,
mannan, ß-D-glucan and D-arabinitol-based assays), (iii) host-derived biomarker detection tests
(Candida albicans germ tube antibodies or CAGTA, anti-mannan antibodies, other infection-specific
antibodies, procalcitonin, serum amyloid A, interleukin 17, interleukin 23 and transforming growth factor
ß-based assays), (iv) clinical prediction algorithms (Candida score, Candida colonization index and
other prediction rules), and (v) leading-edge molecular, proteomic and immunomic technologies (such as
peptide nucleic acid-fluorescent in situ hybridization or PNA-FISH, T2 magnetic resonance or
T2Candida assay, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry or
MALDI-TOF MS, among others). Their strengths, utility, limitations as well as combined use to assist
in the diagnosis of this life-threatening and costly fungal infection (including candidemia and deepseated
candidiasis) are also discussed.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献